DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients

Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study

(2011) Roujun Peng et al.   BREAST

Breast cancer in very young women

(2011) S. Liukkonen et al.   EJSO

Traditional and new prognosticators in breast cancer: Nottingham index, Mib-1 and  estrogen receptor signaling remain the best predictors of relapse and survival in a series of 289 cases

(2010) Tiziana Megha et al.   CANCER BIOLOGY & THERAPY

Current and emerging biomarkers in breast cancer: prognosis and prediction

(2010) Marion T Weigel et al.   ENDOCRINE-RELATED CANCER

Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients

(2009) Shuzhen Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors

(2008) Olivier Brouckaert et al.   BREAST CANCER RESEARCH AND TREATMENT

Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

(2008) M. Dowsett et al.   CLINICAL CANCER RESEARCH

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

(2008) B. Gazic et al.   CYTOPATHOLOGY